Adherence and discontinuation of oral hormonal therapy in patients with hormone receptor positive breast cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Adherence and discontinuation of oral hormonal therapy in patients with hormone receptor positive breast cancer
Authors
Keywords
Aromatase inhibitors, Breast cancer, Hormonal therapy, Medication adherence, Tamoxifen
Journal
International Journal of Clinical Pharmacy
Volume 36, Issue 1, Pages 45-54
Publisher
Springer Nature
Online
2013-08-10
DOI
10.1007/s11096-013-9833-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based study
- (2012) Annette Wigertz et al. BREAST CANCER RESEARCH AND TREATMENT
- Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review
- (2012) Caitlin C. Murphy et al. BREAST CANCER RESEARCH AND TREATMENT
- Prescription refill, patient self-report and physician report in assessing adherence to oral endocrine therapy in early breast cancer patients: a retrospective cohort study in Catalonia, Spain
- (2012) R Font et al. BRITISH JOURNAL OF CANCER
- A new taxonomy for describing and defining adherence to medications
- (2012) Bernard Vrijens et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Early discontinuation of tamoxifen intake in younger women with breast cancer: Is it time to rethink the way it is prescribed?
- (2012) Laetitia Huiart et al. EUROPEAN JOURNAL OF CANCER
- Pharmaceutical care for patients with breast and ovarian cancer
- (2012) Andrea Liekweg et al. SUPPORTIVE CARE IN CANCER
- Adjuvant endocrine therapy with tamoxifen in young women with breast cancer: determinants of interruptions vary over time
- (2011) C. Cluze et al. ANNALS OF ONCOLOGY
- Five-year patterns of adjuvant hormonal therapy use, persistence, and adherence among insured women with early-stage breast cancer
- (2011) Larissa Nekhlyudov et al. BREAST CANCER RESEARCH AND TREATMENT
- Use of tamoxifen and aromatase inhibitors in a large population-based cohort of women with breast cancer
- (2011) L Huiart et al. BRITISH JOURNAL OF CANCER
- Association Between Prescription Co-Payment Amount and Compliance With Adjuvant Hormonal Therapy in Women With Early-Stage Breast Cancer
- (2011) Alfred I. Neugut et al. JOURNAL OF CLINICAL ONCOLOGY
- Guidelines for good database selection and use in pharmacoepidemiology research
- (2011) Gillian C. Hall et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Effect of a 36-month pharmaceutical care program on pharmacotherapy adherence in elderly diabetic and hypertensive patients
- (2011) Paulo Roque Obreli-Neto et al. International Journal of Clinical Pharmacy
- Adherence to long-term adjuvant hormonal therapy for breast cancer
- (2011) Carolyn Gotay et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Predictors of non-adherence to aromatase inhibitors among commercially insured women with breast cancer
- (2010) Rebecca L. Sedjo et al. BREAST CANCER RESEARCH AND TREATMENT
- Comprehensive CYP2D6 genotype and adherence affect outcome in breast cancer patients treated with tamoxifen monotherapy
- (2010) Alastair M. Thompson et al. BREAST CANCER RESEARCH AND TREATMENT
- Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer
- (2010) Dawn L. Hershman et al. BREAST CANCER RESEARCH AND TREATMENT
- Half of breast cancer patients discontinue tamoxifen and any endocrine treatment before the end of the recommended treatment period of 5 years: a population-based analysis
- (2010) Myrthe P. P. van Herk-Sukel et al. BREAST CANCER RESEARCH AND TREATMENT
- Effect of Concomitant CYP2D6 Inhibitor Use and Tamoxifen Adherence on Breast Cancer Recurrence in Early-Stage Breast Cancer
- (2010) Vincent O. Dezentjé et al. JOURNAL OF CLINICAL ONCOLOGY
- The Pharmaceutical care of patients with type 2 diabetes mellitus
- (2010) Anna Paula de Sá Borges et al. PHARMACY WORLD & SCIENCE
- Breast cancer as a global health concern
- (2009) Steven S. Coughlin et al. Cancer Epidemiology
- The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
- (2009) Alessandro Liberati et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Adjuvant Hormonal Therapy Use Among Insured, Low-Income Women With Breast Cancer
- (2009) Gretchen Kimmick et al. JOURNAL OF CLINICAL ONCOLOGY
- Noncompliance with adjuvant radiation, chemotherapy, or hormonal therapy in breast cancer patients
- (2008) Aye Moe Thu Ma et al. AMERICAN JOURNAL OF SURGERY
- Quality of life in patients with breast cancer before and after diagnosis: an eighteen months follow-up study
- (2008) Ali Montazeri et al. BMC CANCER
- Letrozole Compared With Tamoxifen for Elderly Patients With Endocrine-Responsive Early Breast Cancer: The BIG 1-98 Trial
- (2008) Diana Crivellari et al. JOURNAL OF CLINICAL ONCOLOGY
- Adherence to Initial Adjuvant Anastrozole Therapy Among Women With Early-Stage Breast Cancer
- (2008) Ann H. Partridge et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial
- (2008) LANCET ONCOLOGY
- Predictors of Tamoxifen Discontinuation Among Older Women With Estrogen Receptor–Positive Breast Cancer
- (2007) Cynthia Owusu et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now